Top Markets
Coin of the day
Autobio Diagnostics Co., Ltd. Autobio Diagnostics Co., Ltd.

Autobio Diagnostics Co., Ltd.

603658
Rang in Aktien #5354
Autobio Diagnostics Co., Ltd. specializes in the full lifecycle of clinical... Autobio Diagnostics Co., Ltd. specializes in the full lifecycle of clinical diagnostic products, from their initial research and development to manufacturing and market distribution. Their diverse offerings encompass a range of reagents for immunoassay, biochemistry, microbiology, and in-vitro diagnostics (IVD). Additionally, they provide advanced automated and semi-automated instrumentation, alongside comprehensive medical laboratory solutions. Notable immunoassay products include the AutoLumo A2000 Plus automatic chemiluminescence immunoassay analyzer, automated microplate chemiluminescent enzyme immunoassays, LUmo luminometers, PHOmo microplate readers, and iWO microplate washers. Within their microbiology division, they offer automated blood culture systems, blood culture bottles, AUTOMIC strips, and mycoplasma IES. Founded in 1998, the company originally operated as Lifeclone Diagnostics Co., Ltd. before adopting its current name, Autobio Diagnostics Co., Ltd., in 2003. Headquartered in Zhengzhou, China, it functions as a subsidiary of Zhengzhou Auto Industrial Co., Ltd.
Aktienkurs
$4.86
Marktkapitalisierung
$2.78B
Veränderung (1 Tag)
0.33%
Veränderung (1 Jahr)
-15.26%
Land
CN
Handel Autobio Diagnostics Co., Ltd. (603658)

Kategorie

Dividendenrendite-Verlauf für Autobio Diagnostics Co., Ltd. (603658)
Dividendenrendite (TTM) von Autobio Diagnostics Co., Ltd. (Aktienkürzel: 603658) zum 2026: 0
Durchschnittliche Dividendenrendite der letzten 5 Jahre: 0.00%
Dividendenrendite-Verlauf für Autobio Diagnostics Co., Ltd. (603658) von 2026 bis 2026
Dividendenrendite am Ende jedes Jahres (TTM)
Jahr Dividendenrendite ändert
Nicht genügend Daten für die angegebenen Daten.
Dividendenrenditen (TTM) für ähnliche Unternehmen oder Wettbewerber